ATE149569T1 - Verfahren zur herstellung von impfstoffen oder toxoiden - Google Patents
Verfahren zur herstellung von impfstoffen oder toxoidenInfo
- Publication number
- ATE149569T1 ATE149569T1 AT90914003T AT90914003T ATE149569T1 AT E149569 T1 ATE149569 T1 AT E149569T1 AT 90914003 T AT90914003 T AT 90914003T AT 90914003 T AT90914003 T AT 90914003T AT E149569 T1 ATE149569 T1 AT E149569T1
- Authority
- AT
- Austria
- Prior art keywords
- toxoids
- colonized
- pathogenic
- producing vaccines
- microorganisms
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001717 pathogenic effect Effects 0.000 abstract 4
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/430,491 US5149532A (en) | 1989-11-01 | 1989-11-01 | Method of vaccine or toxoid preparation and immunization by colonization with recombinant microorganisms |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE149569T1 true ATE149569T1 (de) | 1997-03-15 |
Family
ID=23707776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90914003T ATE149569T1 (de) | 1989-11-01 | 1990-08-30 | Verfahren zur herstellung von impfstoffen oder toxoiden |
Country Status (8)
Country | Link |
---|---|
US (1) | US5149532A (de) |
EP (1) | EP0498804B1 (de) |
JP (1) | JPH05501401A (de) |
AT (1) | ATE149569T1 (de) |
CA (1) | CA2072657A1 (de) |
DE (1) | DE69030099T2 (de) |
ES (1) | ES2100893T3 (de) |
WO (1) | WO1991006654A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737521B1 (en) * | 1990-05-11 | 2004-05-18 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
PT652758E (pt) * | 1992-06-18 | 2000-04-28 | Harvard College | Vacinas de toxina da difteria |
US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
AU774535B2 (en) * | 1995-10-20 | 2004-07-01 | Actogenix Nv | Delivery of biologically active polypeptides |
GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
US7780961B2 (en) * | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
ATE389415T1 (de) * | 2002-06-19 | 2008-04-15 | Actogenix Nv | Verfahren und mittel zur erhöhung der darmabsorption |
AU2003298291A1 (en) * | 2002-11-15 | 2004-06-15 | Universiteit Gent | Self-containing lactobacillus strain |
AU2006319216B2 (en) | 2005-11-29 | 2012-09-13 | Intrexon Actobiotics Nv | Induction of mucosal tolerance to antigens |
DK3351268T3 (da) | 2007-01-25 | 2020-11-02 | Intrexon Actobiotics Nv | Behandling af immunsygdom ved mukosal indgivelse af antigener |
NZ701881A (en) | 2012-05-16 | 2016-10-28 | Immune Design Corp | Vaccines for hsv-2 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888170A (en) * | 1981-10-22 | 1989-12-19 | Research Corporation | Vaccines obtained from antigenic gene products of recombinant genes |
CA1338705C (en) * | 1981-10-22 | 1996-11-12 | Roy Curtiss Iii | Vaccines obtained from antigenic gene products of recombinant genes |
PT77014B (en) * | 1982-07-20 | 1986-01-24 | Molecular Genetics Inc | Production of herpes simplex viral proteins |
AU589114B2 (en) * | 1984-02-01 | 1989-10-05 | Enterovax Limited | Genetically engineered bacteria useful as a vaccine |
NL8503316A (nl) * | 1985-11-29 | 1987-06-16 | Stichting Nl I Zuivelonderzoek | Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen. |
EP0319690A1 (de) * | 1987-11-24 | 1989-06-14 | Nisshin Flour Milling Co., Ltd. | Verfahren zum Einbringen von Fremd-DNA in bestimmten Bakterien |
-
1989
- 1989-11-01 US US07/430,491 patent/US5149532A/en not_active Expired - Fee Related
-
1990
- 1990-08-30 CA CA002072657A patent/CA2072657A1/en not_active Abandoned
- 1990-08-30 ES ES90914003T patent/ES2100893T3/es not_active Expired - Lifetime
- 1990-08-30 AT AT90914003T patent/ATE149569T1/de not_active IP Right Cessation
- 1990-08-30 JP JP2513027A patent/JPH05501401A/ja active Pending
- 1990-08-30 DE DE69030099T patent/DE69030099T2/de not_active Expired - Fee Related
- 1990-08-30 WO PCT/US1990/004988 patent/WO1991006654A1/en active IP Right Grant
- 1990-08-30 EP EP90914003A patent/EP0498804B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0498804A4 (en) | 1992-12-09 |
DE69030099D1 (de) | 1997-04-10 |
EP0498804B1 (de) | 1997-03-05 |
US5149532A (en) | 1992-09-22 |
CA2072657A1 (en) | 1991-05-02 |
WO1991006654A1 (en) | 1991-05-16 |
ES2100893T3 (es) | 1997-07-01 |
JPH05501401A (ja) | 1993-03-18 |
EP0498804A1 (de) | 1992-08-19 |
DE69030099T2 (de) | 1997-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69536091D1 (de) | Immunisierung durch Impfung von DNS Transkriptionseinheit | |
ATE44765T1 (de) | Lebend-impfstoff und verfahren zu dessen herstellung. | |
ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
ATE149569T1 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
BR9306984A (pt) | Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo | |
KR890701125A (ko) | 무병원성 미생물 및 이의 용도 | |
FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
LU90203I2 (fr) | Anatoxine diphtérique anatoxine tétanique trois antigènes coquelucheux purifiés (toxine pertussique tp hémagglutinine filamenteuse (haf) et pertactine (protéine de membrane externe 69 kd) et le principal antigène de surface du virus de l'hépatite b (vhb) purfié (infanrix hepb) et ses dérivés pharmaceutiquement acceptables | |
DK0755684T3 (da) | Vaccinekonjugat | |
DE69132417D1 (de) | Impfstoff gegen die Lyme-Krankheit | |
HUP9801223A2 (hu) | Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel | |
BR9106601A (pt) | Adjustante de vacina e processo de obter aumento da resposta imunologica a um antigeno em um ser humano ou animal | |
IE940698L (en) | Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant | |
NZ216119A (en) | Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus | |
ATE107516T1 (de) | Pasteurella-impfstoff. | |
DK0626008T3 (da) | Vaccine, der som en adjuvans indeholder acemannan | |
HUP0104125A2 (hu) | Eljárás szárnyasok intradermális immunizálására inaktivált vakcinákkal | |
DK0636030T3 (da) | Pasteurella haemolytica type A-1-bacterin-toxoid-vaccine | |
NO307815B1 (no) | Levende eller inaktivert parental vaksine mot rotavirusinfeksjon | |
Oya | Present status and future prospects of vaccine development. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |